Description of Business - Additional Information (Details) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | |||
|---|---|---|---|---|---|
Jul. 31, 2026 |
Mar. 25, 2025 |
Jul. 31, 2026 |
Jun. 30, 2026 |
Mar. 31, 2025 |
|
| Description Of Business And Summary Of Significant Accounting Policies [Line Items] | |||||
| Escrow receivable | $ 1.0 | $ 1.0 | |||
| Period of escrow | 15 months | ||||
| Metacrine's FXR Program [Member] | Subsequent Event [Member] | |||||
| Description Of Business And Summary Of Significant Accounting Policies [Line Items] | |||||
| Milestone Payment Received | 5.0 | $ 5.0 | |||
| Escrow amount released | $ 1.0 | ||||
| Minimum [Member] | |||||
| Description Of Business And Summary Of Significant Accounting Policies [Line Items] | |||||
| Percentage of Drug Candidate | 10.00% | ||||
| Metacrine, Inc. [Member] | Metacrine's FXR Program [Member] | |||||
| Description Of Business And Summary Of Significant Accounting Policies [Line Items] | |||||
| Upfront payment paid | $ 10.0 | ||||
| Closing upfront payment | 9.0 | ||||
| Escrow receivable | $ 1.0 | ||||
| Future milestone | $ 50.0 |